Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-exploration study of LY01021 in controlled ovarian stimulation for assisted reproduction
CTR20243419Phase 2Active
- Sponsor
- Yantai Chuanghe Biotechnology
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linzagolix in female infertility, sponsored by Yantai Chuanghe Biotechnology. Started Nov 2024; status: active.
02
Drugs
linzagolix
03
Conditions
female infertility
Beyond the preview
Go deeper on CTR20243419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243419.